Table 1 Baseline characteristics of the index patients
From: Efficacy of baloxavir marboxil on household transmission of influenza infection
Variables | Baloxavir group | Oseltamivir group | P value |
|---|---|---|---|
N | 49 | 120 | |
Age of index patients (years), median (IQR) | 33 (13–53) | 26 (10–56) | 0.34 |
0–6 | 2 (4.1) | 20 (16.7) | |
7–19 | 14 (28.6) | 27 (22.5) | |
20–64 | 24 (49.0) | 55 (45.8) | |
≥ 65 | 9 (18.3) | 18 (15.0) | |
Male, n (%) | 27 (55.1) | 65 (54.2) | 0.82 |
Influenza vaccination in the same season, n (%) | 12 (24.5) | 46 (38.3) | 0.08 |
Body temperature (°C) mean ± SD | 38.7 ± 0.94 | 38.4 ± 1.73 | 0.42 |
Respiratory tract symptom, n (%) | 22 (44.9) | 46 (38.3) | 0.43 |